Pathkey.AI Ltd (ASX:PKY)

Australia flag Australia · Delayed Price · Currency is AUD
0.0240
+0.0020 (9.09%)
At close: Aug 27, 2025
9.09%
Market Cap7.10M
Revenue (ttm)321.99K
Net Income (ttm)-1.45M
Shares Out295.98M
EPS (ttm)-0.01
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume25,291
Average Volume122,790
Open0.0240
Previous Close0.0220
Day's Range0.0240 - 0.0240
52-Week Range0.0200 - 0.0250
Beta1.06
RSIn/a
Earnings DateAug 29, 2025

About Pathkey.AI

Pathkey.AI Ltd engages in the development of digital tools that enhance healthcare experience for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs for pharmaceuticals, medical devices, alternative therapies, and novel conditions. It also provides TrialGen, an AI-powered tool streamlines clinical trial design process for biopharma, MedTech, government, and healthcare organizations. The company was formerly known as Opyl Limited a... [Read more]

Industry Metal Mining
Founded 1994
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol PKY
Full Company Profile

Financial Performance

In 2025, Pathkey.AI's revenue was 321,991, a decrease of -19.02% compared to the previous year's 397,637. Losses were -1.45 million, -53.75% less than in 2024.

Financial Statements

News

There is no news available yet.